Evaluation of serum neopterin, periostin, Tenascin-C, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-2 levels in obese pregnant women
dc.authorid | MELEKOGLU, RAUF/0000-0001-7113-6691 | |
dc.authorid | yuce, hande/0000-0003-2907-2019 | |
dc.authorid | unuvar, songul/0000-0001-8454-490X | |
dc.authorid | CETIN, Asli/0000-0003-3902-3210 | |
dc.authorid | YASAR, Seyma/0000-0003-1300-3393 | |
dc.authorwosid | MELEKOGLU, RAUF/AAF-1614-2019 | |
dc.authorwosid | Yaşar, Şeyma/ABI-8055-2020 | |
dc.contributor.author | Melekoglu, Rauf | |
dc.contributor.author | Unuvar, Songul | |
dc.contributor.author | Turkmen, Nese Basak | |
dc.contributor.author | Cetin, Asli | |
dc.contributor.author | Celik, Nesibe Zeyveli | |
dc.contributor.author | Yuce, Hande | |
dc.contributor.author | Yasar, Seyma | |
dc.date.accessioned | 2024-08-04T20:10:19Z | |
dc.date.available | 2024-08-04T20:10:19Z | |
dc.date.issued | 2022 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objective: To investigate the role of extracellular matrix proteins in the molecular mechanism of inflammatory response in obese pregnant women by comparing serum levels of neopterin, periostin, Tenascin-C, tissue inhibitor of metalloproteinase-1, and matrix metalloproteinase-2 between obese and normal weight pregnant women in the third trimester. Materials and Methods: A prospective cross-sectional study was conducted between April 2021 and December 2021. A total of 84 pregnant women were included and three groups were formed with 28 participants in each group. Results: Serum levels of neopterin, periostin, Tenascin-C and tissue inhibitor of metalloproteinase-1 were significantly higher in class II-III obese pregnant women than in class I obese and normal-weight women (p=0.002, p<0.001, p<0.001, and p<0.001, respectively). There was no significant difference in serum matrix metalloproteinase-2 levels between the groups (p=0.769). Receiver operating characteristic curve analysis showed that Tenascin-C and periostin were effective in predicting pre-eclampsia [area under the curve (AUC)=0.82, 95% confidence interval (CI), 0.72-0.90, p<0.001 and AUC=0.71, 95% CI, 0.60-0.80, p=0.007, respectively]. Conclusion: This study demonstrated that class II-III obese pregnant women had significantly higher serum levels of neopterin, periostin, Tenascin-C, and tissue inhibitor of metalloproteinase-1 in the third trimester. These higher serum levels may be associated with the adverse perinatal effects of obesity during pregnancy. | en_US |
dc.identifier.doi | 10.4274/tjod.galenos.2022.70593 | |
dc.identifier.endpage | 267 | en_US |
dc.identifier.issn | 2149-9322 | |
dc.identifier.issn | 2149-9330 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 36511564 | en_US |
dc.identifier.scopus | 2-s2.0-85147038554 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 257 | en_US |
dc.identifier.trdizinid | 1175376 | en_US |
dc.identifier.uri | https://doi.org/10.4274/tjod.galenos.2022.70593 | |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/1175376 | |
dc.identifier.uri | https://hdl.handle.net/11616/92696 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000921197500003 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.relation.ispartof | Turkish Journal of Obstetrics and Gynecology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Neopterin | en_US |
dc.subject | obesity | en_US |
dc.subject | periostin | en_US |
dc.subject | pregnancy | en_US |
dc.subject | Tenascin-C | en_US |
dc.subject | tissue inhibitor of metalloproteinase-1 | en_US |
dc.title | Evaluation of serum neopterin, periostin, Tenascin-C, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-2 levels in obese pregnant women | en_US |
dc.type | Article | en_US |